Beijing Huagen Anbang Technology

Beijing Huagen Anbang Technology is a biotechnology company based in Beijing, China, specializing in the development of advanced molecular diagnostic solutions. The company utilizes its proprietary Cross-Priming Amplification (CPA) technology, an isothermal nucleic acid amplification method, to provide rapid and sensitive detection of various pathogens. Their product portfolio includes diagnostic kits for human infectious diseases, such as COVID-19 and respiratory infections, as well as veterinary applications like African Swine Fever. Huagen Anbang offers a complete diagnostic workflow, including nucleic acid extraction systems, portable amplification instruments, and ready-to-use reagents designed for point-of-care and field testing.